Generic Drugs Market: Is 2026 the Year "Biosimilars"...

added blog Health

2026-03-05 11:24:19 -

Generic Drugs Market: Is 2026 the Year "Biosimilars" Finally Disrupt the $100 Billion Biologics Monopoly

The year 2026 marks a historic turning point for the Generic Drugs Market as the "Biosimilar" segment reaches a critical mass. Accounting for roughly 13% of the market in 2026, biosimilars are now the primary growth engine for industry giants like Sandoz and Teva. In 2026, the launch of biosimilars for blockbuster drugs like Stelara (ustekinumab) has introduced discounts of over 80% off the...

0 Comments 0 Shares 74 Views 0 Reviews